Search research articles
Contact Us
Filters
Showing results (31-40 of 78) with videos related to
Page
of 8
Sort By:
Pigment Cell & Melanoma Research
|
March 21, 2024
Characterization of PRAME immunohistochemistry reveals lower expression in pediatric melanoma compared to adult melanoma
Stephan Forchhammer, Valentin Aebischer, Daniela Lenders, et al.
Journal for Immunotherapy of Cancer
|
October 9, 2025
Exceptional tumor-free survival of a patient with metastatic intrahepatic cholangiocarcinoma after surgery and personalized peptide vaccination: revisiting a striking case
Ana Maia, Juliane Schuhmacher, Silvio Nadalin, et al.
Frontiers in Oncology
|
August 28, 2025
Adjuvant anti-PD-1 therapy improves melanoma-specific survival in stage IIIC-IV melanoma patients with high tumor mutation burden and <i>BRAF V600</i> mutation
Julia Forschner, Julia Huynh, Christopher Schroeder, et al.
Cancers
|
March 1, 2020
MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal Melanoma
Andrea Forschner, Franz-Joachim Hilke, Irina Bonzheim, et al.
Nature Communications
|
October 9, 2024
Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibition
Christopher Schroeder, Sergios Gatidis, Olga Kelemen, et al.
Frontiers in Neurology
|
January 11, 2020
Single Molecule Molecular Inversion Probes for High Throughput Germline Screenings in Dystonia
Michaela Pogoda, Franz-Joachim Hilke, Ebba Lohmann, et al.
British Journal of Cancer
|
March 27, 2023
Detection of circulating cell-free HPV DNA of 13 HPV types for patients with cervical cancer as potential biomarker to monitor therapy response and to detect relapse
Suzana Mittelstadt, Olga Kelemen, Jakob Admard, et al.
British Journal of Cancer
|
April 9, 2026
Genetic landscape of stage II melanoma identifies CBL as a new driver gene and prognostic biomarker
Elena Sophia Lindner, Jakob Admard, German Demidov, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 27, 2020
PET/MRI and genetic intrapatient heterogeneity in head and neck cancers
Kerstin Clasen, Sara Leibfarth, Franz J Hilke, et al.
Frontiers in Oncology
|
March 18, 2021
Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma
Andrea Forschner, Tobias Sinnberg, Gabi Mroz, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 78) with videos related to
Sort By:
Page
of 8
Pigment Cell & Melanoma Research
|
March 21, 2024
Characterization of PRAME immunohistochemistry reveals lower expression in pediatric melanoma compared to adult melanoma
Stephan Forchhammer, Valentin Aebischer, Daniela Lenders, et al.
Journal for Immunotherapy of Cancer
|
October 9, 2025
Exceptional tumor-free survival of a patient with metastatic intrahepatic cholangiocarcinoma after surgery and personalized peptide vaccination: revisiting a striking case
Ana Maia, Juliane Schuhmacher, Silvio Nadalin, et al.
Frontiers in Oncology
|
August 28, 2025
Adjuvant anti-PD-1 therapy improves melanoma-specific survival in stage IIIC-IV melanoma patients with high tumor mutation burden and <i>BRAF V600</i> mutation
Julia Forschner, Julia Huynh, Christopher Schroeder, et al.
Cancers
|
March 1, 2020
MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal Melanoma
Andrea Forschner, Franz-Joachim Hilke, Irina Bonzheim, et al.
Nature Communications
|
October 9, 2024
Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibition
Christopher Schroeder, Sergios Gatidis, Olga Kelemen, et al.
Frontiers in Neurology
|
January 11, 2020
Single Molecule Molecular Inversion Probes for High Throughput Germline Screenings in Dystonia
Michaela Pogoda, Franz-Joachim Hilke, Ebba Lohmann, et al.
British Journal of Cancer
|
March 27, 2023
Detection of circulating cell-free HPV DNA of 13 HPV types for patients with cervical cancer as potential biomarker to monitor therapy response and to detect relapse
Suzana Mittelstadt, Olga Kelemen, Jakob Admard, et al.
British Journal of Cancer
|
April 9, 2026
Genetic landscape of stage II melanoma identifies CBL as a new driver gene and prognostic biomarker
Elena Sophia Lindner, Jakob Admard, German Demidov, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 27, 2020
PET/MRI and genetic intrapatient heterogeneity in head and neck cancers
Kerstin Clasen, Sara Leibfarth, Franz J Hilke, et al.
Frontiers in Oncology
|
March 18, 2021
Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma
Andrea Forschner, Tobias Sinnberg, Gabi Mroz, et al.
Page
of 8